A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer
- 1 January 2019
- journal article
- review article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 157 (1) , 362-373.e8
Abstract
No abstract availableKeywords
Funding Information
- Varian Medical Systems
- Boehringer Ingelheim
- Pfizer
- National Institutes of Health (P30 CA008748)
- AstraZeneca
This publication has 57 references indexed in Scilit:
- Management of Single Malignant Lung Nodules in Elderly Patients (70 Years or Older) Who are Not Candidates for LobectomyAmerican Journal of Clinical Oncology, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010
- Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor sizeRadiation Oncology, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumorsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Reducing Bias in Observational Studies Using Subclassification on the Propensity ScoreJournal of the American Statistical Association, 1984
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983